Clinical Trial Update: A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) [Phase 3]

View source ↗

Summary

Clinical trial update: phase 3 study of tersolisib (LY4064809/STX-478) in combination with other anti-cancer therapies for advanced breast cancer with a PIK3CA …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tersolisib (tersolisib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Neoplasms, Neoplasm Metastasis | Phase 3 | Status: RECRUITING